Gordon Naylor
Chair

Gordon has enjoyed a long and successful international business career. For over 30 years he was a key part of the internationalisation of the CSL Group, a global specialty biotechnology company that was established in Australia and grew to become Australia’s largest public company. Gordon held a range of business and functional leadership roles within CSL including Chief Financial Officer. At the time of his retirement from CSL, he was the President of Seqirus where he led the 3-year turnaround of that business into one of the most successful vaccine companies in the world. In 2016 Seqirus was highly unprofitable with a turnover of circa $700m.

By 2019 the business generated circa $150m EBIT from a turnover of $1.2b.

Leon Hoare
Non-Executive Director

Leon is the Managing Director of Lohmann & Rauscher Australia & New Zealand (ANZ), a private EU based medical device company. Previously, he was Managing Director of Smith & Nephew ANZ (all divisions) until 2015, one of the Smith & Nephew’s largest global subsidiaries outside the USA. He served as President of Smith & Nephew’s Asia Pacific Advanced Wound Management (AWM) business for 5 years and was a member of the Global Executive Management for the AWM Division. In his 24 years with Smith & Nephew, he also held roles in Marketing, Divisional and General Management. His career has also included a senior role at Bristol-Myers Squibb (medical devices), and as Vice-Chair of Australia’s peak medical device industry body, Medical Technology Association of Australia.

Leon is also the chair of the MVP Human Resources Committee. He is also a non-executive director of PolyNovo Limited.

Christine Emmanuel-Donnelly
Non-Executive Director

Christine is an experienced patent and trademark attorney, and a business development professional having more than 30 years’ experience locally and internationally. She is a former Executive Manager of Business Development and Commercial at the CSIRO, where she founded and led the management of CSIRO’s IP team and managed the growth of the CSIRO equity portfolio for over 5 years. Prior to this role, Christine was in-house IP Counsel for Unilever in the UK and practised as a patent and trademark attorney for Wilson Gunn (UK) and Davies Collison Cave and Griffith Hack in Melbourne.

Christine is also currently non-executive director of Polynovo Ltd, IP & Commercialisation Manager at RMIT University, Vice President of the Council of Patent & Trademarks Attorneys of Australia and on the Life Sciences Council of SPE Australia.

Russell Basser
Non-Executive Director

Dr Basser is a qualified physician, with over 30 years of international medical and biopharmaceutical experience. Dr Basser has worked worked as a medical oncologist in Melbourne prior to joining CSL in 2001.

During his 21 years at CSL, he held multiple global executive roles, including Head of Global Clinical Development, Chief Medical Officer and Senior VP of Research and Development for CSL Seqirus. Dr Basser has substantial expertise in international drug and vaccine development and spent several years based in the USA.

Dr Basser currently serves as a non-executive director on the Boards of Starpharma Holdings Limited and Doherty Clinical Trials. He has previously served on the Board of the ANZ Breast Cancer Trials Group and the Hadassah Australia Medical Research Collaboration.

Mary Sontrop
Non-Executive Director

Mary has extensive international experience in the biopharmaceutical sector across manufacturing operations, quality, and business integration. During her 28 years with CSL, Mary was an integral part of CSL’s globalisation through a series of major acquisitions. This included primary responsibility for the turnaround of unprofitable manufacturing operations. Subsequently as head of global plasma manufacturing, Mary delivered an integrated manufacturing network spanning four countries. As head of CSL’s ANZ pharmaceutical business, Mary and her team delivered Australia’s most successful adolescent /adult immunisation program and achieved US FDA approval of CSL’s seasonal and pandemic influenza vaccines.

Mary holds a Bachelor of Applied Science, Graduate Diplomas in Quality Management and Administration (Health) and a Master of Business Administration. Mary is an experienced non-executive director (currently on the Board of IDT Australia Ltd) and a Graduate of the Australian Institute of Company Directors. She also has significant international governance experience.

Richard Betts
Non-Executive Director

Richard is an experienced executive who has held senior roles with ASX listed entities over 20 years. He is currently CFO at Ridley Corporation Limited and was previously CFO at Pact Group Holdings Ltd for 6 years. Prior to that he held divisional finance and other executive roles at Orica Limited. These roles provided a deep understanding of working in various jurisdictions, including North America, Europe and Asia. Richard has extensive financial and governance experience within international manufacturing environments.